The Wall Street Journal
@wsj.com
Exclusive: The FDA has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used.
FDA Launches Study of Abortion Pill Safety as Opponents Push for Limits
The effort is expected to take about six months, meaning its results would come after the midterm elections.
on.wsj.com
9:17 PM · Jun 4, 2026
Exclusive: The FDA has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used.
— The Wall Street Journal (@wsj.com) 2026-06-05T01:17:34.415619Z
Exclusive Policy
FDA Launches Study of Abortion Pill Safety as Opponents Push for Limits
The effort is expected to take about six months, meaning its results would come after the midterm elections
By Liz Essley Whyte
June 4, 2026 9:00 pm ET

Several boxes of Mifeprex (Mifepristone) tablets, 200 mg, abortion medication, are in a white box.
The FDAs website currently says that mifepristone, approved decades ago, is safe to use as indicated. Kayana Szymczak for WSJ
WASHINGTONThe Food and Drug Administration has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used.
The study marks a victory for antiabortion groups and Republican members of Congress, who have demanded action from the administration to crack down on the pills use. In recent months, antiabortion allies had lost patience with assurances from administration officials that a study would be conducted.
{snip}
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8